Filing Details
- Accession Number:
- 0001209191-24-001198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-08 20:06:58
- Reporting Period:
- 2024-01-05
- Accepted Time:
- 2024-01-08 20:06:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1633932 | Essa Pharma Inc. | EPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826322 | Peter Virsik | C/O Essa Pharma Inc. 999 West Broadway, Suite 720 Vancouver A1 V5Z 1K5 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2024-01-05 | 699 | $6.11 | 14,022 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The amount reflects the sale of shares pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.
Billionaire Hedge Funds
